Medicines

For more than 140 years, we have worked tirelessly to develop and deliver trusted medicines that meet real needs.

On this page you will find Product Monographs and Patient Medication Information (also known as Consumer Information). You will also find instructions on how to use our devices. Documents provided here are for informational use and for residents of Canada only.

Lilly Canada is committed to keeping people informed about the availability of our medicines. In the event of a shortage or discontinuation, we will post an update on the website of Drug Shortages Canada.

If you are a customer and have questions about Lilly medicines, please call our Customer Response Centre at 1-888-545-5972 or submit your questions using this online form. If you are seeking medical advice, contact your health care provider.

Re-usable Devices – Humalog® and Humulin® Family of Products

Instructions for Use - HumaPen® Luxura®
HumaPen® Luxura® pens are no longer distributed in Canada.

Instructions for Use - HumaPen Luxura® HD

Instructions for Use - HumaPen Savvio®

® Registered trademark owned by Eli Lilly and Company; used under license.

^TM Trademark owned by Eli Lilly and Company; used under license.

®* Registered trademark of ImClone LLC; used under license.

®+ Registered trademark of Boehringer Ingelheim International GmbH; used under license. Basaglar, Glyxambi, Jardiance, Jentadueto, Synjardy and Trajenta are part of the Boehringer Ingelheim–Lilly Alliance.

®± Registered trademark owned by R.P. Scherer Technologies, Inc., a Catalent Pharma Solutions Company

Medicines

Expand accordion Adcirca® (tadalafil tablets)

Expand accordion Alimta® (pemetrexed disodium for injection)

Expand accordion Basaglar® (insulin glargine [rDNA origin] injection)

Expand accordion Baqsimi® (glucagon nasal powder)

Expand accordion Cialis® (tadalafil tablets)

Expand accordion Cymbalta® (duloxetine hydrochloride delayed release capsules)

Expand accordion Cyramza® (ramucirumab intravenous injection)

Expand accordion Emgality® (galcanezumab injection)

Expand accordion Entuzity® KwikPen® (insulin injection 500 units/mL, human biosynthetic)

Expand accordion Erbitux®∗ (cetuximab intravenous injection)

Expand accordion Evista® (raloxifene hydrochloride tablets)

Expand accordion Forteo® (teriparatide [rDNA origin] injection)

Expand accordion Glucagon (glucagon for injection, rDNA origin)

Expand accordion Glyxambi®+ (empagliflozin and linagliptin tablets)

Expand accordion Humalog® (insulin lispro for injection)

Expand accordion Humalog® 200 units/mL KwikPen® (insulin lispro for injection)

Expand accordion Humalog® Mix25® (25% insulin lispro injection, 75% insulin lispro protamine suspension)

Expand accordion Humalog® Mix50® (50% insulin lispro injection, 50% insulin lispro protamine suspension)

Expand accordion Humatrope® (somatropin for injection)

Expand accordion Humulin® N (insulin isophane, human biosynthetic, rDNA origin for injection); Humulin® R (insulin, human biosynthetic for injection); Humulin® 30/70 (30% insulin injection, 70% insulin isophane, human biosynthetic, rDNA origin)

Expand accordion Jardiance®+ (empagliflozin tablets)

Expand accordion Jentadueto®+ (linagliptin and metformin hydrochloride tablets)

Expand accordion Mounjaro™ (tirzepatide injection)

Expand accordion Olumiant® (baricitinib tablets)

Expand accordion Prozac® (fluoxetine hydrochloride capsules)

Expand accordion Retevmo™ (selpercatinib capsules)

Expand accordion Strattera® (atomoxetine capsules)

Expand accordion Synjardy®+ (empagliflozin and metformin hydrochloride tablets)

Expand accordion Taltz® (ixekizumab for injection)

Expand accordion Trajenta®+ (linagliptin tablets)

Expand accordion Trulicity® (dulaglutide injection)

Expand accordion Verzenio® (abemaciclib tablets)

Expand accordion Zyprexa® (olanzapine tablets); Zyprexa® Zydis®± (olanzapine orally disintegrating tablets); Zyprexa® IntraMuscular (olanzapine tartrate for injection)

Re-usable Devices – Humalog® and Humulin® Family of Products